secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001654954-24-007730
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Zivo shareholders elect Masterson as director, ratify BDO, approve say-on-pay
-----------------------------------------------------------------------------

- Nola E. Masterson elected Class II director (1,155,796 for, 80,935 withheld; 625,589 broker non-votes).
- BDO USA, LLP ratified as auditor for FY 2024 (1,767,252 for, 94,680 against, 388 abstain).
- Advisory say-on-pay approved (1,191,591 for, 44,773 against, 367 abstain; 625,589 broker non-votes).
- Total shares voted: 1,862,320 (66.4% of outstanding common stock).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424007730/0001654954-24-007730-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424007730/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-007730

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer